IL6 and neoplasm: Overall, further research is needed to elucidate the precise conditions under which IL-6 either boosts or impairs tumor immunity, with the ultimate aim of limiting IL-6-targeting therapies to scenarios in which it enhances the response to cancer immunotherapy.